{"entity":{"id":"nct07023627","kind":"trial","name":"A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression","aka":["MAESTRA 1"],"tldr":"A phase 2 trial of INCB123667 in ovarian cancer, run by Incyte Corporation, now recruiting.","summary":"A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression is a phase 2 interventional study registered as NCT07023627 by Incyte Corporation, with 160 participants planned, started 2025-11-12 and due to reach its primary completion in 2027-04-27. Interventions recorded: INCB123667. Conditions listed: Ovarian Cancer. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT07023627","url":"https://clinicaltrials.gov/study/NCT07023627"}],"tags":["ctgov-ingest"],"related":[],"cancers":["ovarian","platinum-resistant-ovarian-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["incb123667"],"companies":["incyte"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07023627","phase":"2","setting":"A Phase 2, Single-Arm Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression (MAESTRA 1)","sponsor":"Incyte Corporation","participation":[{"nct":"NCT07023627","source":"https://clinicaltrials.gov/study/NCT07023627","fetchedAt":"2026-10-07T16:55:22.250Z","studySha256":"b236336914f789460704137790507cb0695a8834f1bf99b60d026f6862b75c89","overallStatus":"RECRUITING","lastUpdatePosted":"2026-09-15","leadSponsor":"Incyte Corporation","collaboratorCount":2,"minimumAge":"18 Years","maximumAge":"99 Years","sex":"FEMALE","healthyVolunteers":false,"hasEligibility":true,"enrolment":160,"enrolmentType":"ESTIMATED","siteCount":74,"recruitingSiteCount":74,"countries":["Australia","Belgium","Japan","Puerto Rico","Spain","Switzerland","United Kingdom","United States"]}],"started":"2025-11-12","startedType":"actual","enrolled":160,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07023627/","neighbours":{"cancer":[{"id":"ovarian","kind":"cancer","name":"Ovarian cancer","route":"/cancers/ovarian/"},{"id":"platinum-resistant-ovarian-cancer","kind":"cancer","name":"Platinum-resistant ovarian cancer","route":"/cancers/platinum-resistant-ovarian-cancer/"}],"drug":[{"id":"incb123667","kind":"drug","name":"INCB123667","route":"/drugs/incb123667/"}],"company":[{"id":"incyte","kind":"company","name":"Incyte","route":"/companies/incyte/"}]}}